Budget 2014 provisions relevant to life sciences companies
By Samuel Rippon
The Budget this year contained fewer items of headline interest than Budgets of the past. However, there are a few developments that are of particular interest for those operating in the life sciences sector.
R&D tax credits: the repayable tax credit for small and medium-sized enterprises is to be increased from 11 per cent to 14.5 per cent. This means that loss-making companies in this size bracket could reclaim up to £32.62 in repayable tax credit for every £100 of qualifying expenditure.
Corporation tax rate: as previously announced, the main rate of UK corporation tax was cut to 21 per cent with effect from 1 April this year. It will reduce by a further one per cent with effect from April 2015…
Click on the link below to read the rest of the Bristows briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Bristows
News from The Lawyer
Briefings from Bristows
The High Court has held that in certain circumstances the European Insolvency Regulations 1346/2000/EC may effectively extend the jurisdictional reach of the English courts.
A recent decision may result in a potentially more expansive basis for establishing jurisdiction over defendants in Europe.